Sanofi has held talks with Abbott Laboratories, Mylan and private equity firms over the possible sale of a 6.3 billion euro ($8.5 billion) portfolio of mature drugs, according to an internal document seen by Reuters.
The 25-page document, a copy of which was circulated by the CGT union on Wednesday, details a plan presented to the company’s investment committee on May 6 dubbed the “Phoenix project.
Help employers find you! Check out all the jobs and post your resume.
